Search Results - C. Cremolini

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study by V. Massa, F. Signorini, F. Salani, M.E. Filice, G. Grelli, P. Lippolis, P. Faviana, V. Genovesi, S. Santi, C. Vivaldi, S. Cesario, A. Bertolucci, C. Cremolini, V. Nardini, G. Masi, C. Ugolini, L. Fornaro

    Published in ESMO Gastrointestinal Oncology (2024-09-01)
    Get full text
    Article


  2. 2

    Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type ci... by G. Martini, D. Ciardiello, V. Famiglietti, D. Rossini, C. Antoniotti, T. Troiani, S. Napolitano, L. Esposito, T. P. Latiano, E. Maiello, M. Del Re, S. Lonardi, G. Aprile, D. Santini, G. Masi, A. Avallone, N. Normanno, F. Pietrantonio, C. Pinto, F. Ciardiello, C. Cremolini, E. Martinelli

    Published in Cancer Medicine (2023-04-01)
    Get full text
    Article


  3. 3

    Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study by G. Mazzoli, F. Nichetti, K. Shitara, R. Cohen, S. Lonardi, C. Cremolini, M.E. Elez, J. Chao, M. Fakih, S.J. Klempner, P. Jayachandran, S. Maron, D. Cowzer, L. Fornaro, L. Salvatore, V. Zhu, Y. Aoki, R. Cerantola, F. Bergamo, M. Salati, M. Ambrosini, G. Sabella, G. Randon, M.J. Overman, T. André, F. Pietrantonio

    Published in ESMO Gastrointestinal Oncology (2024-03-01)
    Get full text
    Article


Search Tools: